Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and PTC Therapeutics (NASDAQ:PTCT).
Amicus Therapeutics has a consensus price target of $16.00.
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $11.015 last updated September 25, 2024 at 12:18 PM EDT.
There are no upcoming dividends for Amicus Therapeutics.
Amicus Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Amicus Therapeutics.
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.